Dr Reddys Laboratories (RDY) Enterprise Value (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Enterprise Value of -$166.0 million for Q1 2026, up 7.26% year-over-year from -$154.8 million in Q1 2025, and up 7.26% quarter-over-quarter from -$179.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Enterprise Value (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Enterprise Value history runs 18 years deep, the most recent figure standing at -$166.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 7.26% year-over-year to -$166.0 million; the TTM figure through Mar 2026 stood at -$166.0 million (up 7.26% YoY), while the FY2026 annual figure was -$166.0 million, up 7.26% from the prior year.
- Enterprise Value for Q1 2026 stood at -$166.0 million, up from -$179.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$87.0 million in Q1 2024, with the low at -$612.0 million in Q1 2023.
- The 5-year median for Enterprise Value is -$179.0 million (2025), against an average of -$336.0 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value tumbled 351.91% in 2023, then soared 85.78% in 2024.
- Dr Reddys Laboratories' Enterprise Value stood at -$131.0 million in 2022, then plunged by 351.91% to -$592.0 million in 2023, then soared by 85.3% to -$87.0 million in 2024, then sank by 105.75% to -$179.0 million in 2025, then advanced by 7.26% to -$166.0 million in 2026.
- Business Quant data shows RDY's Enterprise Value at -$166.0 million in Q1 2026, -$179.0 million in Q1 2025, and -$87.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.00 Mn |
| Mar 31, 2025 | -179.00 Mn |
| Mar 31, 2024 | -87.00 Mn |
| Jun 30, 2023 | -592.00 Mn |
| Mar 31, 2023 | -612.00 Mn |
| Jun 30, 2022 | -131.00 Mn |
| Mar 31, 2022 | -585.00 Mn |
| Mar 31, 2021 | -220.00 Mn |
| Dec 31, 2020 | -11.00 Mn |
| Sep 30, 2020 | 19.00 Mn |
| Mar 31, 2020 | -341.00 Mn |
| Dec 31, 2019 | -56.00 Mn |
| Sep 30, 2019 | 15.00 Mn |
| Mar 31, 2019 | -37.00 Mn |
| Dec 31, 2018 | 255.00 Mn |
| Jun 30, 2018 | 544.00 Mn |
| Mar 31, 2018 | 395.00 Mn |
| Dec 31, 2017 | -344,000.00 Bn |
| Sep 30, 2017 | -263,000.00 Bn |
| Jun 17, 2017 | 781.00 Mn |